Generic Name
Zolmitriptan
Brand Names
Zolmiptriptan, ZOMIG
FDA approval date: May 14, 2013
Classification: Serotonin-1b and Serotonin-1d Receptor Agonist
Form: Spray, Tablet
What is Zolmiptriptan (Zolmitriptan)?
Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks. Zolmitriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan tablets have not been established for cluster headache. Zolmitriptan tablets are a serotonin 1B/1D receptor agonist indicated for the acute treatment of migraine with or without aura in adults Limitations of Use: Use only after a clear diagnosis of migraine has been established Not indicated for the prophylactic therapy of migraine Not indicated for the treatment of cluster headache.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment



